1. Home
  2. FLYX vs PEPG Comparison

FLYX vs PEPG Comparison

Compare FLYX & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLYX
  • PEPG
  • Stock Information
  • Founded
  • FLYX 2015
  • PEPG 2018
  • Country
  • FLYX United States
  • PEPG United States
  • Employees
  • FLYX N/A
  • PEPG N/A
  • Industry
  • FLYX Blank Checks
  • PEPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLYX Finance
  • PEPG Health Care
  • Exchange
  • FLYX Nasdaq
  • PEPG Nasdaq
  • Market Cap
  • FLYX 39.4M
  • PEPG 45.9M
  • IPO Year
  • FLYX N/A
  • PEPG 2022
  • Fundamental
  • Price
  • FLYX $4.59
  • PEPG $1.48
  • Analyst Decision
  • FLYX
  • PEPG Buy
  • Analyst Count
  • FLYX 0
  • PEPG 4
  • Target Price
  • FLYX N/A
  • PEPG $7.25
  • AVG Volume (30 Days)
  • FLYX 36.5K
  • PEPG 372.4K
  • Earning Date
  • FLYX 11-13-2025
  • PEPG 11-06-2025
  • Dividend Yield
  • FLYX N/A
  • PEPG N/A
  • EPS Growth
  • FLYX N/A
  • PEPG N/A
  • EPS
  • FLYX N/A
  • PEPG N/A
  • Revenue
  • FLYX $347,746,000.00
  • PEPG N/A
  • Revenue This Year
  • FLYX $28.47
  • PEPG N/A
  • Revenue Next Year
  • FLYX $22.44
  • PEPG N/A
  • P/E Ratio
  • FLYX N/A
  • PEPG N/A
  • Revenue Growth
  • FLYX 17.09
  • PEPG N/A
  • 52 Week Low
  • FLYX $1.79
  • PEPG $0.88
  • 52 Week High
  • FLYX $4.95
  • PEPG $10.06
  • Technical
  • Relative Strength Index (RSI)
  • FLYX 66.32
  • PEPG 60.65
  • Support Level
  • FLYX $4.21
  • PEPG $1.35
  • Resistance Level
  • FLYX $4.40
  • PEPG $1.85
  • Average True Range (ATR)
  • FLYX 0.48
  • PEPG 0.13
  • MACD
  • FLYX -0.01
  • PEPG 0.02
  • Stochastic Oscillator
  • FLYX 72.51
  • PEPG 48.68

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: